Treatment of eumycetoma with ketoconazole.

Abstract

Ten patients with eumycetoma were treated with oral ketoconazole in the dosage of 400mg/day for 8 to 24 months. In eight cases the foot was affected: four were due to Madurella mycetomatis and one each due to M grisea, Pyrenochaeta romeroi, Acremonium kiliense and A falciorme. One mycetoma which affected the back and perineum was due to A kiliense, and one case presented with multiple sebaceous cysts and the scalp and M mycetomatis was isolated from the lesion. Clinical and laboratory tests showed excellent tolerance to the drug, with no adverse reactions. Complete cure was obtained in six patients and two showed good responses. The cured patients were followed up for a period ranging from three months to two years without any evidence of recurrence.

• Authors: P V Venugopal, T V Venugopal
• Journal: The Australasian journal of dermatology (Australas J Dermatol) Vol. 34 Issue 1 Pg. 27-9 ( 1993) ISSN: 0004-8380 [Print] Australia
• PMID: 8240184 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Ketoconazole

Topics

• Acremonium (classification, isolation & purification)
• Adolescent
• Adult
• Female
• Foot Dermatoses (drug therapy, microbiology, pathology)
• Humans
• Ketoconazole (administration & dosage, therapeutic use)
• Male
• Middle Aged
• Mitosporic Fungi (classification, isolation & purification)
• Mycetoma (drug therapy, microbiology, pathology)
• Remission Induction